Inactive Instrument

Insiders Five Prime Therapeutics, Inc.

Equities

FPRX

US33830X1046

Insiders

Unlock all the news: Be the first to know and act before the market!

Five Prime Therapeutics, Inc. Announces Board Changes	21-04-16	CI
Insider Trends: Insider Adds to Selling Trend at Five Prime Therapeutics	20-11-13	MT
Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of Five Prime Therapeutics Stock	20-11-06	MT
Five Prime Therapeutics, Inc. Appoints Thomas Civik as President and Chief Executive Officer and a Member of the Board of Directors	20-04-22	CI
Five Prime Therapeutics, Inc. Announces Management Changes	20-04-14	CI
Five Prime Therapeutics, Inc. Announces Board Changes	19-12-26	CI
Five Prime Therapeutics, Inc. Announces Management Transition	19-09-19	CI
Five Prime Therapeutics, Inc Announces Promotes Helen Collins Om Senior Vice President and Chief Medical Officer to Executive Vice President and Chief Medical Officer	19-08-22	CI
Five Prime Therapeutics Appoints Lori Lyons-Williams to Its Board of Directors	19-06-24	CI
Five Prime Therapeutics, Inc. Announces the Departure of Dr. Sheila Gujrathi from its Board of Directors	19-06-09	CI
Five Prime Therapeutics, Inc. Appoints Carol Schafer to its Board of Directors	19-05-15	CI
Five Prime Therapeutics, Inc. Announces the Resignation of Bryan Irving as Executive Vice President and Chief Scientific Officer, Effective May 30, 2019	19-05-08	CI
Five Prime Therapeutics, Inc. Announces Principal Accounting Officer Changes	19-03-04	CI
Five Prime Therapeutics, Inc. Announces Changes to its Board of Directors	18-11-29	CI
Five Prime Therapeutics, Inc. Appoints David V. Smith as Executive Vice President and Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, Effective November 26, 2018	18-11-05	CI
Five Prime Therapeutics Appoints Bryan Irving, as Chief Scientific Officer	18-05-15	CI
Five Prime Therapeutics, Inc Appoints Linda Rubinstein as Interim Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer	18-04-17	CI
Five Prime Therapeutics, Inc. Announces Retirement of Fred E. Cohen from Board	18-03-30	CI
Five Prime Therapeutics Announces Resignation of Marc Belsky as Senior Vice President and Chief Financial Officer, to Continue in Current Role Until April 6, 2018	18-03-13	CI
Five Prime Therapeutics, Inc. Announces Executive Changes, Effective January 1, 2018	17-10-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Five Prime Therapeutics, Inc.

Equities

FPRX

US33830X1046

Insiders

Filters